O-91 First line treatment with gemcitabine (G) and vinorelbine (V) versus cisplatin (C) gemcitabine and vinorelbine (CGV) in advanced non small cell lung cancer (NSCLC). Preliminary results of a randomised study of the GON (Grupo Oncológico del Norte de Espan˜a) | Publicación